Bath Savings Trust Co lowered its position in shares of Roche Holding Ltd. (OTCMKTS:RHHBY) by 19.0% during the 4th quarter, HoldingsChannel reports. The firm owned 36,650 shares of the company’s stock after selling 8,620 shares during the period. Bath Savings Trust Co’s holdings in Roche were worth $1,159,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of the business. Parametric Portfolio Associates LLC lifted its holdings in shares of Roche by 5.6% in the third quarter. Parametric Portfolio Associates LLC now owns 3,806,074 shares of the company’s stock worth $121,794,000 after buying an additional 200,394 shares in the last quarter. Lenox Wealth Management Inc. lifted its holdings in shares of Roche by 49.0% in the third quarter. Lenox Wealth Management Inc. now owns 98,282 shares of the company’s stock worth $3,145,000 after buying an additional 32,335 shares in the last quarter. Chickasaw Capital Management LLC lifted its holdings in shares of Roche by 33.3% in the fourth quarter. Chickasaw Capital Management LLC now owns 40,000 shares of the company’s stock worth $1,265,000 after buying an additional 10,000 shares in the last quarter. Stonebridge Capital Advisors LLC purchased a new position in shares of Roche in the third quarter worth $221,000. Finally, Patten Group Inc. lifted its holdings in shares of Roche by 12.2% in the third quarter. Patten Group Inc. now owns 29,741 shares of the company’s stock worth $847,000 after buying an additional 3,239 shares in the last quarter. 0.58% of the stock is currently owned by institutional investors and hedge funds.
Shares of Roche Holding Ltd. (OTCMKTS RHHBY) traded down $0.24 on Wednesday, reaching $31.59. 309,139 shares of the company traded hands, compared to its average volume of 1,660,000. Roche Holding Ltd. has a 12 month low of $28.48 and a 12 month high of $36.82. The company has a market capitalization of $219,380.00, a PE ratio of 22.09, a PEG ratio of 2.23 and a beta of 0.67. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.29 and a quick ratio of 0.92.
Roche Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding Ltd. (OTCMKTS:RHHBY).
What are top analysts saying about Roche? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Roche and related companies.